The Nayak laboratory pursues basic and translational research into stem cell regeneration of the upper airway epithelium using animal models and human tissues obtained from sinus surgery.

The Frock lab uses genome-wide chromosomal translocation sequencing technologies to understand DNA double-strand break (DSB) repair. They apply these technologies to develop cancer diagnostics/treatments and to improve gene editing approaches.

The Loh Laboratory employs stem cells to reconstitute and understand human developmental biology, with the intention of generating pure populations of desired human tissue progenitors and creating a platform for stem cell-driven regenerative medicine.

Dr. Krane's current research interests involve the management of pain in children using intraspinal opioids, regional anesthetics, and novel analgesic agents; and cerebral and osmolar complications of diabetic ketoacidosis in children.

The Mercola laboratory is focused on developing new therapies for cardiovascular disease: their research combines in vitro disease models using cardiovascular cells generated from induced pluripotent stem cells with high throughput screening to define disease mechanisms, identify drug targets and develop drug leads.

Dr. So is interested in the diagnosis and treatment of neuromuscular diseases, including amyotrophic lateral sclerosis, neuropathies, myasthenia gravis, and electrophysiological characterization of these disorders.

Dr. Dubra's lab uses adaptive optics, a technology originally developed to observe distant stars and galaxies, to improve the optics of the eye so that individual retinal and blood cells can be visualized.

Dr. Enns's research interests include novel means of diagnosing and treating mitochondrial disorders, with an emphasis on antioxidant therapy, lysosomal disorders, and newborn screening by tandem mass spectrometry.

Dr. Lambert's research has focused on improving the visual outcomes of children with congenital cataracts.

Dr. Cowan's research looks to further our understanding of the pathophysiology of metabolic diseases, with the ultimate aim of improving patient testing and developing new therapeutic strategies.